Value-based pricing approaches for oncology products in Germany
Value-based pricing for oncology products in Germany requires a different approach to pre-launch price forecasting. GPI…
Category eBooks
Navigating MFN: Turn risk into predictable outcomes
MFN pharmaceutical pricing exposure isn’t discovered — it’s built. The launch and pricing decisions teams make…
Analogue benchmarking for orphan drug pricing
Analogue benchmarking for orphan drug pricing solves the problem that stops traditional methods in their tracks:…
The Pricing Inflection Point – Why 2026 Will Redefine Pharma Market Access and Pricing Strategy
The pharmaceutical pricing strategy decisions made in 2026 will define commercial performance for years to come.…
What if medicines were priced like airlines?
Dynamic or Adaptive pricing: Aligning value and access across the lifecycle.
Transforming launch strategy: A 5-step intelligence framework
Transform scattered market data into systematic launch advantage with intelligence-powered strategy frameworks
GPI’s USA pricing data
A solution to challenges associated with the fragmented USA payersystem for market access and pricing decisions.
Transforming clinical feasibility: A 5-step intelligence framework
Transform weeks of manual research into hours of strategicanalysis with platform-powered intelligence
